Invivyd reports sustained neutralization activity of PEMGARDA™ against dominant SARS-CoV-2 variants, supporting its ongoing emergency use status. Quiver AI Summary Invivyd, Inc. announced new in vitro ...

In the cohort that received the BA.5-containing bivalent booster, the neutralizing activity against all the omicron subvariants as compared with that against WA1/2020 was better than in the other two ...

WALTHAM, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today provided ...